AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00992810 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lateral-to-Medial Approach
Description: Approach of the needle to administer the brachial plexus nerve block will be done in a lateral-to-medial direction.
Study NCT00992810 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Media-to-Lateral Approach
Description: Approach of the needle to administer the brachial plexus nerve block will be done in a medial-to-lateral direction.
Study NCT00691496 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral intervention to reduce sexual risk among African-American men who have sex with men
Description: 5 week intervention to increase skill level of participants with talking to their social networks and sexual partners about reducing high risk sexual behaviors while preparing a healthy meal
Study NCT01904708 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acute Moderate Intensity Exercise
Description: Moderate intensity exercise by walking on a treadmill at 75% of max heart rate.
Study NCT03202004 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2894512 1% cream
Description: 1 % (10 mg/g) GSK2894512 cream will be provided in tubes labeled in compliance with country requirements.
Study NCT04445246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inhaled ILOPROST
Description: Inhaled Iloprost 20 mcg every 8 hours for 5 days only delivered by nebulization.
Study NCT01923935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BUSULFEX®
Description: BUSULFEX® 3.2 mg/kg/day iv once daily over 3 hours (day-6\~day-4)
Study NCT01923935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alkeran®
Description: Alkeran® 70 mg/m2/day iv once daily over 30 minutes (day-3\~day-2)
Study NCT03686176 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: A child life specialist will fit the patient with the goggles, select a game, and initiate play once the medical procedure begins.
Study NCT01434355 — intervention group
Intervention type: OTHER
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT01434355 — intervention group
Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT04321096 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camostat Mesilate
Description: Serine protease inhibitor that blocks TMPRSS-2 mediated cell entry of SARS-CoV-2
Study NCT03202004 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle cream
Description: Vehicle cream will be provided in tubes labeled in compliance with country requirements.
Study NCT00359684 — intervention group
Intervention type: DRUG
Intervention: Cysteamine
Description: Cystine-depleting agent
Study NCT04001790 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Project Search plus ASD Supports
Description: Nine month job training program embedded on Fort Eustis military base.
Study NCT02461173 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Merional
Description: On the 3rd day of menstruation women will have a vaginal ultrasound and will receive daily intramuscular 150 IU of human menopausal gonadotropins (hMG, Merional ®, IBSA, Lugano, Switzerland) starting from the 3nd day of menstruation.
Study NCT02461173 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: IUI
Description: Semen will be processed and drawn into a shepherd catheter attached to a 1 mL syringe and injected into the uterus
Study NCT02461173 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ovulation detection
Description: Women will be asked to test their morning urine specimen for luteinizing hormone daily starting 4 days before the expected day of ovulation. This will be done using a qualitative kit
Study NCT02461173 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Choriomon
Description: Administration of 10000 IU of human chorionic gonadotropin (hCG; Choriomon®, IBSA) when at least 2 follicles measuring 18 mm are observed during vaginal ultrasound and is associated with serum E2 of 500-3000 Pg/mL
Study NCT02461173 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: shepherd catheter
Study NCT04338685 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO7119929
Description: RO7119929 will be administered orally as a capsule
Study NCT04338685 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Description: Tocilizumab will be administered in case of severe steroid-refractory cytokine release syndrome.~Tocilizumab will be administered as concentrate for solution for IV infusion at a dose: for participants > 30 kg: 8 mg/kg, for participants \< 30 kg: 12mg/kg IV
Study NCT04566016 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Regional anesthesia
Description: Patients scheduled for lower limb arterial bypass surgery will be randomly allocated for treatment with spinal anesthesia associated with spontaneous ventilation (nasal cannula with supplemental oxygen - Group 1) or treatment with general anesthesia under controlled mechanical ventilation (tidal volume 6 to 8 ml / kg of the predicted body weight and PEEP of 5 cmH2O - Group 2).
Study NCT04566016 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Regional anesthesia
Description: Patients scheduled for lower limb arterial bypass surgery will be randomly allocated for treatment with spinal anesthesia associated with spontaneous ventilation (nasal cannula with supplemental oxygen - Group 1) or treatment with general anesthesia under controlled mechanical ventilation (tidal volume 6 to 8 ml / kg of the predicted body weight and PEEP of 5 cmH2O - Group 2).
Study NCT03427931 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitor (CGM)
Description: Study subjects will collect Continuous Glucose Monitor data for a minimum of 28 days but may continue for up to 3 months.
Study NCT03378531 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AEB1102
Description: modified human arginase I
Study NCT04321096 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral tablet
Description: Placebo
Study NCT02451995 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ripple Mapping guided AT ablation
Description: Diagnosing the mechanism and delivering ablation within the atria in patients with atrial tachycardia on the basis of Ripple Mapping
Study NCT02451995 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Local activation Time Mapping AT Ablation
Description: Diagnosing the mechanism and delivering ablation within the atria in patients with atrial tachycardia on the basis of local activation time mapping
Study NCT00779025 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PD-F-5254
Description: Female Personal Lubricant (MINE)
Study NCT00779025 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PD-F-5254
Description: Female Personal Lubricant (MINE)
Study NCT00779025 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 10855-096
Description: Male Personal Lubricant (YOURS)
Study NCT05971927 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Simulation education
Description: Randomly assigned experimental group students performed eight different vaginal examination scenarios in the laboratory on the fetal monitoring and labor progress model set for cervical dilatation, cervical effacement, presenting fetal part, presence of amniotic membrane and fetal descent. The researchers repeated the vaginal examination scenario and informed the students about the evaluation results after each student had performed the vaginal examination scenario prepared by the researchers. This process continued until the experimental group students completed eight different vaginal examination scenarios.
Study NCT03941717 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Condition
Description: Each script for the mindfulness-based intervention was slightly modified to fit the context of a venipuncture, and begins with instructions to take deep breaths. Both scripts aim to cultivate present moment awareness of experiences, curiosity, nonjudgement, and acceptance of experiences as they unfold. In particular, the scripts ask that the participant visualize their worries and feelings as a cloud in the sky, and probes for curious thoughts about these experiences. The temporary nature of sensations is described, and the participant is asked to keep this openness and curiosity during the venipuncture.
Study NCT03941717 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Unfocused attention Condition
Description: Each script for the unfocused attention task instructs participants to allow their mind and thoughts to roam. The aim is to encourage the participant to continue thinking and mind wandering as they typically would.
Study NCT02716623 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CR diet
Description: Diet consists of meals lower in carbohydrates but does not restrict the number of calories that participants can consume.
Study NCT02716623 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Participants will be asked to undergo specific exercise schedule. Exercise will be tracked using a fitness device.
Study NCT04191317 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pain Neuroscience Education and gradual exposure
Description: Education covering the pathophysiology of apin and exercises based on the gradual exposure principle
Study NCT04191317 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pilates and postural education
Description: Postural education and pilates exercises
Study NCT03031366 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3d roadmap guidance
Description: TIPS was established using 3d roadmap
Study NCT03031366 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional TIPS procedure
Description: conventional TIPS procedure using wedged hepatic venography
Study NCT02246426 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Computerized plasticity-based adaptive cognitive training
Description: Computerized plasticity-based adaptive cognitive training for a total maximum of 40 treatment sessions, 3-5 times weekly, 40-60 minutes per session.
Study NCT02246426 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Commercially available computerized training
Description: Commercially available computerized training for a total maximum of 40 treatment sessions, 3-5 times weekly, 40-60 minutes per session.
Study NCT01771523 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Thyroidectomy
Description: total thyroidectomy or lobectomy
Study NCT01771523 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: use of drain
Description: drain will be used
Study NCT00475709 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Trifecta Aortic Heart Valve
Description: Surgical replacement of the aortic valve with the Trifecta Aortic Heart Valve.
Study NCT03081884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FACBC PET-CT Imaging
Description: Participants will fast for 4 hours to normalize their neutral amino acid levels. One hour prior to the scan, participants will drink up to 450ml of standard oral contrast. Participants will lie on the scanning bed while the bed moves through the PET/CT scanner for the CT portion of the exam. After completion of the CT scan, approximately 10 units of FACBC will be injected for the PET scan portion of the exam. The bed will move through the scanner again and the PET portion of the exam will take 30 minutes. The entire visit will take about two hours.~Standard of care procedures include conventional imaging (CT and/or MRI; bone scan and/or NaF PET per institutional standards) and radical prostatectomy with extended pelvic lymph node dissection.
Study NCT01223729 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetyl-L-Carnitine
Description: 2 g acetyl-L carnitine twice a day
Study NCT01223729 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo twice per day
Study NCT02197663 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: acupuncture(44mm in length and 32-gauge)
Description: The whole course of the acupuncture contains 24times(about 3 months). The acupoints are fixed and located over head and limbs.~The whole course of the sham acupuncture contains 24times(about 3 months). The acupoints are fixed and 1cm away from meridian and no acupoints over head were chosen.
Study NCT02197663 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: acupuncture(44mm in length and 32-gauge)
Description: The whole course of the acupuncture contains 24times(about 3 months). The acupoints are fixed and located over head and limbs.~The whole course of the sham acupuncture contains 24times(about 3 months). The acupoints are fixed and 1cm away from meridian and no acupoints over head were chosen.
Study NCT00983320 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: quetiapine
Description: flexible dosage (50 to 300 mg)
Study NCT00983320 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study NCT00666406 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method (rAHF-PFM)
Description: Infusion of 50 +/- 5 IU/kg bodyweight
Study NCT00666406 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Recombinant Factor VIII (rAHF)
Description: Infusion of 50 +/- 5 IU/kg bodyweight
Study NCT01622673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MINTOX® Maximum Strength
Description: 20 mL MINTOX® Maximum Strength (MS)~Throughout the study, participants will continue to take raltegravir every 12 hours along with their other HIV medications. There will be a minimum of 2 days washout between treatment periods. On the day of co-dosing and intensive PK sampling, raltegravir will be dosed in the morning in a fasted state in all periods.
Study NCT01368653 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard treatment
Description: Standard treatment includes a 6-week supply of 21-mg nicotine patches and 4 15-minute individual smoking cessation counseling sessions to help smokers quit smoking
Study NCT01368653 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard treatment+practice quitting
Description: This intervention includes standard treatment (a 6-week supply of 21-mg nicotine patches and 4 15-minute individual smoking cessation counseling session) and an experimental treatment that involves practice quitting 7 times prior to a target quit date (for 4-12 hours per day) and returning to smoking by puffing smoke without inhaling
Study NCT01368653 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Very low nicotine cigarettes
Description: This intervention will be offered to a subset of smokers from both of the other study arms. To be eligible for this intervention, participants must be smoking at the follow-up interview conducted four weeks after a target quit day in the two arms listed above. Tobacco cigarettes containing very low levels of nicotine (.016-.019 mg in smoke from the cigarettes). These are to be smoked no more often than a smoker normally smokes regular cigarettes and for no longer than 6 weeks.
Study NCT03196453 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Probiotic
Description: probiotic and/or placebo intervention in toddlers
Study NCT03196453 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic
Description: probiotic and/or placebo intervention in toddlers
Study NCT04363645 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multicontext (MC) approach
Description: The Multicontext approach is a metacognitive intervention designed to improve awareness, strategy use, and executive functioning.
Study NCT01328483 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intrapartum Oropharyngeal Suctioning
Description: After delivery of the head, the infant's mouth and nose were suctioned. Nose was suctioned after the mouth and throat. Oropharyngeal suctioning was performed using a 10 french suction catheter with suction pressure of 100mm Hg or De Lee's suction trap in event of electricity failure or non availability of suction machine
Study NCT03187249 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy
Description: 12 weeks cognitive-behavioral lessons, once a week
Study NCT03187249 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation Therapy
Description: 12 weeks pulmonary rehabilitation exercise
Study NCT03187249 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Combined Therapy
Description: cognitive-behavioral lessons and pulmonary rehabilitation exercise for 12 weeks
Study NCT02319304 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: FOLFOX {5-fluorouracil (5-FU), leucovorin, and oxaliplatin}
Description: see arm description
Study NCT02319304 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Low dose fractionated radiation therapy (LDFRT)
Description: see arm description
Study NCT01019824 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ralfinamide
Description: Ralfinamide Oral Tablets, 160 or 320 mg per day
Study NCT02496182 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet only with the excipients of the Pirfenidone tablet
Study NCT02496182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pirfenidone
Description: Conventional Treatment (Prednisone+Azathioprine) plus Pirfenidone 1800 mg
Study NCT02496182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pirfenidone
Description: Conventional Treatment (Prednisone+Azathioprine) plus Pirfenidone 1200 mg
Study NCT01019824 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ralfinamide
Description: Ralfinamide Oral Tablets, 160 or 320 mg per day
Study NCT02077556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Everolimus
Description: Everolimus: 1 mg orally every 12 hours from post-operation day 1 to achieve trough concentrations of 3-8 ng/mL
Study NCT02077556 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mycophenolate mofetil
Description: Mycophenolate mofetil: 10-15 mg/kg orally every 12 hours from post-operation day 1 (decrease 50% dose if white blood cell \< 4000/mcL)
Study NCT02077556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Description: Tacrolimus: 0.05-0.075 mg/kg orally every 12 hours from post-operation day 1 to achieve trough concentrations of 8-12 ng/mL
Study NCT02077556 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tacrolimus
Description: Tacrolimus: 0.05-0.075 mg/kg orally every 12 hours from post-operation day 1 to achieve trough concentrations of 8-12 ng/mL
Study NCT02077556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Description: Methylprednisolone: 50 mg iv every 6 hours on post-operation day 1, 40 mg iv every 6 hours on post-operation day 2, 30 mg iv every 6 hours on post-operation day 3, 20 mg iv every 6 hours on post-operation day 4, 20 mg iv every 8 hours on post-operation day 5, 20 mg iv every 12 hours on post-operation day 6, 20 mg iv on post-operation day 7
Study NCT02077556 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methylprednisolone
Description: Methylprednisolone: 50 mg iv every 6 hours on post-operation day 1, 40 mg iv every 6 hours on post-operation day 2, 30 mg iv every 6 hours on post-operation day 3, 20 mg iv every 6 hours on post-operation day 4, 20 mg iv every 8 hours on post-operation day 5, 20 mg iv every 12 hours on post-operation day 6, 20 mg iv on post-operation day 7
Study NCT02077556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisolone
Description: Prednisolone: 20 mg orally once a day from post-operation day 8 to post-operation week 4, then titrated gradually
Study NCT02500953 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASP3325
Study NCT02077556 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisolone
Description: Prednisolone: 20 mg orally once a day from post-operation day 8 to post-operation week 4, then titrated gradually
Study NCT02135445 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-385
Description: TAK-385 tablet
Study NCT02135445 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Degarelix
Description: Degarelix injection
Study NCT03202056 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: Dry needling is a skilled intervention that uses a thin filiform needle to penetrate the skin and stimulate underlying myofascial trigger points, muscular, and connective tissues for the management of neuromusculoskeletal pain and movement impairments.
Study NCT03202056 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Dry needling
Description: Sham Dry needling use a non-penetrating acupuncture needle
Study NCT02010086 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Individual Cognitive Behavioral Therapy
Description: Therapists will work with families for 32 weekly sessions, each lasting 90 minutes, implementing the CBT manual for children with ASD (Wood et al., 2007).
Study NCT02010086 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Community Treatment
Description: In this condition, the child meets with a therapist for 32 weekly sessions, each 90 minutes. Therapists use an established manual to provide a standard community therapy treatment.